Switzerland COMCO competition commission terminates Novartis probe without consequences
Written By : Ruchika Sharma
Published On 2024-10-11 07:00 GMT | Update On 2024-10-11 07:00 GMT
Berlin: Switzerland's COMCO competition commission said on Thursday that it has terminated a probe against Novartis into possibly using blocking patents.
COMCO opened the probe in September 2022 to determine whether the pharmaceutical giant intended to unlawfully protect one if its medicines by filing various patent infringement lawsuits, the commission said in a statement.
As per Reuters, the statement added, "The investigation revealed that Novartis' actions finally were common practice in the field of patent law and, further, did not confirm the above indications of an unlawful restraint of competition."
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.